Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Bellerophon Therapeutics, Inc. | 7,386,163 | reported | 17 Sept 2018 | tx 6+739,370 |
| ALIMERA SCIENCES INC | 3,177,842 | reported | 27 Apr 2010 | tx 7+3,949,070−3,642,999 |
| Trubion Pharmaceuticals, Inc | 308,367 | reported | 23 Oct 2006 | tx 3+308,367−302,527 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 Sept 2018 | PURCHASE | Bellerophon Therapeutics, Inc. | 75,000 | 1.23 USD | |
| 13 Sept 2018 | PURCHASE | Bellerophon Therapeutics, Inc. | 75,000 | 1.19 USD | |
| 17 Sept 2018 | PURCHASE | Bellerophon Therapeutics, Inc. | 60,000 | 1.18 USD | |
| 15 Aug 2018 | PURCHASE | Bellerophon Therapeutics, Inc. | 272,000 | 0.65 USD | |
| 14 Aug 2018 | PURCHASE | Bellerophon Therapeutics, Inc. | 190,977 | 0.65 USD | first after silence |
| 16 Aug 2018 | PURCHASE | Bellerophon Therapeutics, Inc. | 66,393 | 0.65 USD | |
| 27 Apr 2010 | CONVERSION | ALIMERA SCIENCES INC | 2,243,732 | — | |
| 27 Apr 2010 | PURCHASE | ALIMERA SCIENCES INC | 306,071 | 11.00 USD | first after silence |
| 27 Apr 2010 | CONVERSION | ALIMERA SCIENCES INC | 465,157 | — | |
| 27 Apr 2010 | CONVERSION | ALIMERA SCIENCES INC | 934,110 | — | |
| 27 Apr 2010 | CONVERSION | ALIMERA SCIENCES INC | 2,243,732 | 0.00 USD | deriv |
| 27 Apr 2010 | CONVERSION | ALIMERA SCIENCES INC | 465,157 | 0.00 USD | deriv |
| 27 Apr 2010 | CONVERSION | ALIMERA SCIENCES INC | 934,110 | 0.00 USD | deriv |
| 23 Oct 2006 | CONVERSION | Trubion Pharmaceuticals, Inc | 302,527 | — | |
| 23 Oct 2006 | PURCHASE | Trubion Pharmaceuticals, Inc | 5,840 | 13.00 USD | |
| 23 Oct 2006 | CONVERSION | Trubion Pharmaceuticals, Inc | 302,527 | — | deriv |
2 purchases reported after at least 12 months of silence — most recent on 14 Aug 2018.